about
Sap transporter mediated import and subsequent degradation of antimicrobial peptides in HaemophilusThe novel human β-defensin 114 regulates lipopolysaccharide (LPS)-mediated inflammation and protects sperm from motility lossCapsule polysaccharide mediates bacterial resistance to antimicrobial peptidesStructure and mechanism of ArnA: conformational change implies ordered dehydrogenase mechanism in key enzyme for polymyxin resistanceCrystal structure of Escherichia coli ArnA (PmrI) decarboxylase domain. A key enzyme for lipid A modification with 4-amino-4-deoxy-L-arabinose and polymyxin resistanceStrategies and molecular tools to fight antimicrobial resistance: resistome, transcriptome, and antimicrobial peptidesMucosal Inflammatory Response to Salmonella typhimurium InfectionAntimicrobial peptides: their role as infection-selective tracers for molecular imagingAntimicrobial peptides in 2014The two-domain LysX protein of Mycobacterium tuberculosis is required for production of lysinylated phosphatidylglycerol and resistance to cationic antimicrobial peptidesRole of Net Charge on Catalytic Domain and Influence of Cell Wall Binding Domain on Bactericidal Activity, Specificity, and Host Range of Phage LysinsHigh-quality 3D structures shine light on antibacterial, anti-biofilm and antiviral activities of human cathelicidin LL-37 and its fragments.Understanding the regulation of Group B Streptococcal virulence factorsFull virulence of Pseudomonas aeruginosa requires OprFStructures of two bacterial resistance factors mediating tRNA-dependent aminoacylation of phosphatidylglycerol with lysine or alanineGenome sequence of E. coli O104:H4 leads to rapid development of a targeted antimicrobial agent against this emerging pathogenCrystal structure and biochemical characterization of the transmembrane PAP2 type phosphatidylglycerol phosphate phosphatase from Bacillus subtilis.Nucleotide biosynthesis is critical for growth of bacteria in human blood.Successful identification of novel agents to control infectious diseases from screening mixture-based peptide combinatorial libraries in complex cell-based bioassays.The major cold shock gene, cspA, is involved in the susceptibility of Staphylococcus aureus to an antimicrobial peptide of human cathepsin GSqualamine: an appropriate strategy against the emergence of multidrug resistant gram-negative bacteria?Tuning the properties of the bacterial membrane with aminoacylated phosphatidylglycerol.A mutation in the sap operon attenuates survival of nontypeable Haemophilus influenzae in a chinchilla model of otitis media.Looking toward basic science for potential drug discovery targets against community-associated MRSACurcumin increases the pathogenicity of Salmonella enterica serovar Typhimurium in murine model.Human antimicrobial peptides and proteinsProteus mirabilis pmrI, an RppA-regulated gene necessary for polymyxin B resistance, biofilm formation, and urothelial cell invasion.Characterization of UDP-glucose dehydrogenase and UDP-glucose pyrophosphorylase mutants of Proteus mirabilis: defectiveness in polymyxin B resistance, swarming, and virulence.Staphylococcus colonization of the skin and antimicrobial peptides.The GBS PI-2a pilus is required for virulence in mice neonates.Functional interrelationships between cell membrane and cell wall in antimicrobial peptide-mediated killing of Staphylococcus aureus.Streptococcus iniae phosphoglucomutase is a virulence factor and a target for vaccine developmentCationic methacrylate polymers as topical antimicrobial agents against Staphylococcus aureus nasal colonizationSerratia marcescens arn, a PhoP-regulated locus necessary for polymyxin B resistance.ClpX contributes to innate defense peptide resistance and virulence phenotypes of Bacillus anthracis.A Lactobacillus acidophilus strain of human gastrointestinal microbiota origin elicits killing of enterovirulent Salmonella enterica Serovar Typhimurium by triggering lethal bacterial membrane damage.DltABCD- and MprF-mediated cell envelope modifications of Staphylococcus aureus confer resistance to platelet microbicidal proteins and contribute to virulence in a rabbit endocarditis model.Role of mprF1 and mprF2 in the pathogenicity of Enterococcus faecalis.Conformation of the phosphate D-alanine zwitterion in bacterial teichoic acid from nuclear magnetic resonance spectroscopy.Relative free energy of binding between antimicrobial peptides and SDS or DPC micelles.
P2860
Q21131406-4D594E47-3AE4-450C-8B70-E6119B7E4040Q24324776-20BB8E8D-D499-487E-B0E5-8267B0CA5840Q24559990-9964F076-B5DB-470C-831D-B3CB0BF421ADQ24630632-327742C8-722F-4B84-ABF2-FA5E7A71B589Q24646087-7786FB12-93EF-41C9-921E-66D6CC021EF1Q26861137-931A8BB9-4CEB-4A55-B6B9-91AF44A090F2Q26863143-BF04DF2C-E646-459A-9DC9-65EE3847E0AEQ27014021-D9EF3DFF-A390-4ABE-A740-618F78216DD2Q27027316-33B8A263-9552-4B6A-872E-DB03966EF1ABQ27316484-FC5208FE-CD7E-4F92-B0B7-3BBC73B6B1E9Q27671535-642B4A61-E436-4748-9201-BE15BB274EC9Q27692605-023D3AD3-4D6C-44D7-A780-9C4C7EABE7D4Q28237019-EDC0BDD7-1045-4E9E-83D9-00323B01281BQ28492965-332ED6E7-BED4-4641-B27A-B0A66A12237BQ28493059-6C3AD1E5-F1F6-4F43-A37B-85B1EC1A9B97Q28731303-74C8B05D-4CE8-4928-A09B-4D92BBFD7666Q30398310-25DCC402-1789-426A-BE22-D03360CA447AQ30841127-D5BFFB62-B894-405F-9D3C-DEDE3BA90117Q30937880-E1A52A9B-1448-431A-9057-7402234A6B1CQ33187830-92581B33-B093-443F-8779-0C4AD7B61B4EQ33354067-D346596D-B763-41EF-98D3-6043B56F60CFQ33507347-34BEAB33-80EF-4D19-B26F-826185F11B92Q33557688-A92423ED-C92C-4FE3-8FC2-96DB849C3922Q33560722-4750E800-14DD-45BD-B27C-A139827BD9A3Q33634073-0103A510-45EA-4B79-B2DD-A891948BB460Q33673156-895EA7E0-7E5B-4D15-9A2E-1DBD880C8FA9Q33768793-909DCDD1-0629-484E-827A-09D29DAFD9A3Q33826394-84B797EA-BAEA-44CD-870A-48D057D7DBEAQ33840268-A5F260A8-61F3-446E-92B6-22BAB7207D29Q33883330-85D8BCBE-6754-4EDF-AA54-5858A0810DF8Q33938287-EFA6755B-DD97-47D2-8E84-A7B6C4D12E0BQ34033596-7AA3DF02-B797-4CFC-BD7B-B08AA1988F7FQ34033741-40BC7E13-0879-4FF2-B73E-C2653962F65EQ34057453-89C3EC98-7303-47A9-BFFB-0E6CFB62B5C6Q34061669-886B32BB-527B-4A85-89BC-E3DC9C037441Q34097875-FE2EDEBA-DAC4-436F-8E87-79D0758FFFECQ34194581-16EDC978-49AF-4494-AE2E-0AFE4BE4EDD6Q34313862-5697C428-A25F-49F0-80FA-C7B6F9F78BD6Q34338343-A4CF6062-705C-48C7-95A3-D9B80D7E9CF6Q34343831-AC311526-9CF8-4ED3-AA27-2AF419A77BD8
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
How do bacteria resist human antimicrobial peptides?
@ast
How do bacteria resist human antimicrobial peptides?
@en
How do bacteria resist human antimicrobial peptides?
@nl
type
label
How do bacteria resist human antimicrobial peptides?
@ast
How do bacteria resist human antimicrobial peptides?
@en
How do bacteria resist human antimicrobial peptides?
@nl
prefLabel
How do bacteria resist human antimicrobial peptides?
@ast
How do bacteria resist human antimicrobial peptides?
@en
How do bacteria resist human antimicrobial peptides?
@nl
P1476
How do bacteria resist human antimicrobial peptides?
@en
P2093
Andreas Peschel
P304
P356
10.1016/S0966-842X(02)02333-8
P577
2002-04-01T00:00:00Z